Dengue is a viral infection spread between humans by Aedes aegypti mosquitoes. Dengue causes flu-like symptoms, including intense headaches and joint pains. Published in the journal Science Translational Medicine, professor Cameron Simmons, from the Department of Microbiology and Immunology at the University of Melbourne and the Peter Doherty Institute for Infection and Immunity, says that a discovery could lead to improved strategies to reduce the incidence of dengue.
"We did a 'real world' experiment and allowed mosquitoes infected with Wolbachia and uninfected mosquitoes to feed on the blood of Vietnamese dengue patients. Our team then measured how efficiently Wolbachia blocked dengue virus infection of the mosquito body and saliva, which in turn steps stops them spreading the virus between humans," Simmons says.
Researchers developed a mathematical model of dengue virus transmission and used the experimental results as a basis to predict how well Wolbachia would reduce the intensity of dengue transmission under a variety of scenarios.
"We found that Wolbachia could eliminate dengue transmission in locations where the intensity of transmission is low or moderate. In high transmission settings, Wolbachia would also cause a significant reduction in transmission.
"Our findings are important because they provide realistic measures of the ability of Wolbachia to block transmission of the dengue virus and provide precise projections of its impact on dengue infections," Simmons says.
Wolbachia has been recently introduced into Cairns and Townsville and the results of this study suggest future dengue outbreaks in these cities should be much less severe than in the past. "Our results will enable policy makers in dengue-affected countries to make informed decisions on Wolbachia when allocating scarce resources to dengue control," Simmons says.
Dengue continues to be a major public health problem in Asia and Latin America. Estimates suggest more than 100 million cases occur globally each year.
Source: University of Melbourne
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.